Skip to main content
THCTenet Healthcare CorporationHold6.2·$203.72+6.55%
HoldModerate Confidence
Investment thesis

Tenet Healthcare passed all required investment gates with a 22.4% upside to analyst targets and a favorable 1.86x reward-to-risk ratio, backed by a 4-of-4 earnings beat streak averaging 20.5% above consensus and a free cash flow conversion of 180% of net income — though managed-care payer concentration in 70% of revenue creates a key single-counterparty risk.

Thesis pillars

  • Analyst Upside Margin Of SafetyStable
  • Exceptional Earnings Beat StreakStable
  • Managed Care Payer ConcentrationStable
  • +1 more pillar — see the Why tab for full reasoning

Full reasoning →

Open full analysis

Tenet Healthcare Corporation (THC) Stock Analysis

Recovery setup · Catalyst-Driven edge

HoldModerate Confidence

Healthcare · Medical Care Facilities

Hold if already holding. Not a fresh buy at $203.72, but acceptable to hold if already in. Reasons: Concentration risk — Customer: managed care payers (70.0%); Concentration risk — Customer: top 10 managed care payers (69.0%).

Tenet Healthcare operates 50 acute care and specialty hospitals with 12,494 licensed beds across eight states alongside 533 ambulatory surgery centers and 26 surgical hospitals in 37 states, employing nearly 100,000 people. Revenue flows through Hospital Operations (where... Read more

$203.72+7.4% A.UpsideScore 6.2/10#2 of 36 Medical Care Facilities
QualityF-score7 / 9FCF yield17.45%
Stop $190.28Target $218.87(analyst − 10%)A.R:R 0.5:1
Analyst target$243.19+19.4%21 analysts
$218.87our TP
$203.72price
$243.19mean
$288

Hold if already holding. Not a fresh buy at $203.72, but acceptable to hold if already in. Reasons: Concentration risk — Customer: managed care payers (70.0%); Concentration risk — Customer: top 10 managed care payers (69.0%). Chart setup: Death cross but MACD improving, RSI 77. Maintain position. Not compelling to add more. Score 6.2/10, moderate confidence.

Passes 6/9 gates (positive momentum, clean insider activity, news events none recent, earnings proximity 21d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: moderate.

10-K grounded · weekly refresh

About Tenet Healthcare Corporation

About Tenet Healthcare Corporation

Tenet Healthcare Corporation operated 50 acute care and specialty hospitals with 12,494 licensed beds across eight states, alongside USPI's 533 ambulatory surgery centers and 26 surgical hospitals in 37 states at December 31, 2025, employing nearly 100,000 people across both reporting segments. Managed care payers contributed approximately 70 percent, or $9.696 billion, of net patient service revenues for hospitals and related outpatient facilities in the Hospital Operations segment in 2025, with Medicare and Medicaid adding 15 percent and 11 percent, respectively, excluding managed care versions of those programs.

Revenue flows through two segments: Hospital Operations — encompassing acute care hospitals, 132 outpatient centers, and Conifer Health Solutions, which provided revenue cycle management services to approximately 600 Tenet and non-Tenet hospitals — and Ambulatory Care, structured as physician and health-system joint ventures managed by USPI. The top 10 managed care payers generated 69 percent of managed care net patient service revenues in 2025; the 10-K notes that material payment delays or disputes with any significant payer could have a material adverse effect on financial condition and cash flows. Geographic concentration of outpatient facilities is notable: approximately 74 percent of the outpatient centers in the Hospital Operations segment at December 31, 2025 were in Arizona and Texas. Conifer returned to full Tenet ownership in January 2026 following a strategic transaction with CommonSpirit Health, which had held a 23.8 percent interest.

Show full overview

Federal and state policy changes may weigh on Tenet's revenue materially. The Affordable Care Act's enhanced premium tax credits expired at the end of 2025, and rising health insurance premiums are expected to cause a corresponding rise in the uninsured or shift individuals from commercial coverage to government programs beginning in 2026. The Congressional Budget Office anticipates millions of individuals could lose health insurance between now and 2034 once the OBBBA is implemented, which may reduce Medicaid supplemental payments and delay timing of payments to Tenet's facilities. State-mandated minimum wage increases for California healthcare workers effective October 2024, with further annual increases anticipated through 2028, add ongoing pressure to labor costs at the company's California hospitals.

See also: Healthcare · Medical Care Facilities

From Tenet Healthcare Corporation's most recent 10-K filing, extracted June 16, 2026.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-07-06
TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Fri, Jul 24, 202621d to earnings· next earnings call

Thesis

Rewards
Strong earnings beat streak (4/4)
Attractive valuation
Positive momentum
Risks
Concentration risk — Customer: managed care payers (70.0%)
Concentration risk — Customer: top 10 managed care payers (69.0%)
Thin upside margin: 7.4%

Key Metrics

P/E (TTM)10.6
P/E (Fwd)11.5
Mkt Cap$17.5B
EV/EBITDA6.9
Profit Mgn7.9%
ROE30.3%
Rev Growth2.8%
Beta1.27
DividendNone
Rating analysts27

Quality Signals

Piotroski F7/9MoatNarrow

Options Flow

P/C0.82neutral
IV55%elevated

Concentration Risks(10-K Item 1A)

  • HIGHCustomermanaged care payers70%
    10-K Item 1A: 'approximately 70%, or $9.696 billion, of our net patient service revenues ... was attributable to managed care payers'
  • HIGHCustomertop 10 managed care payers69%
    10-K Item 1A: 'our top 10 managed care payers generated 69% of our managed care net patient service revenues for the year ended December 31, 2025'
  • MEDIUMGeographicArizona and Texas
    10-K Item 1: 'Approximately 74% of the outpatient centers in our Hospital Operations segment at December 31, 2025 were in Arizona and Texas'

Material Events(8-K, last 90d)

  • 2026-04-10Item 5.02LOW
    EVP & CIO Paola Arbour entered Retirement Transition Agreement on April 9, 2026; she will retire from her CIO role effective December 31, 2026 and remain employed part-time through April 1, 2028 providing transition services. No successor named for CIO role.
    SEC filing →
  • 2026-03-30Item 5.02LOW
    SVP & Controller (Principal Accounting Officer) R. Scott Ramsey retirement date shifted to April 30, 2026. Successor J. Michael Grooms appointed SVP & Controller effective April 6, 2026, becoming Principal Accounting Officer May 1, 2026. Previously SVP, Chief Accounting Officer at Lifepoint Health since 2018.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

1 floor-breaker

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

Bollinger
0.0
Support Resistance
0.9
52w Position
6.5
GatesA.R:R 0.5 < 1.5@spotDeath cross (50MA < 200MA)Executive change: officer departure/appointmentMomentum 7.7>=5.5Insider activity: OKNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 21d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARRecoverySuitability: Moderate
RSI
77 · Overbought
20D MA 50D MA 200D MADEATH CROSSSupport $157.58Resistance $208.52

Price Targets

$190
$219
A.Upside+7.4%
A.R:R0.5:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! asymmetry at 0.5 (below the engine's 1.5 threshold)@spot

Earnings

B
B
B
B
4/4 beats
Next Earnings2026-07-24 (21d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is THC stock a buy right now?

Hold if already holding. Not a fresh buy at $203.72, but acceptable to hold if already in. Reasons: Concentration risk — Customer: managed care payers (70.0%); Concentration risk — Customer: top 10 managed care payers (69.0%). Chart setup: Death cross but MACD improving, RSI 77. Maintain position. Not compelling to add more. Target $218.87 (+7.4%), stop $190.28 (−7.1%), A.R:R 0.5:1. Score 6.2/10, moderate confidence.

What is the THC stock price target?

Take-profit target: $218.87 (+7.4% upside). Target $218.87 (+7.4%), stop $190.28 (−7.1%), A.R:R 0.5:1. Stop-loss: $190.28.

What are the risks of investing in THC?

Concentration risk — Customer: managed care payers (70.0%); Concentration risk — Customer: top 10 managed care payers (69.0%); Thin upside margin: 7.4%.

Is THC overvalued or undervalued?

Tenet Healthcare Corporation trades at a P/E of 10.6 (forward 11.5). TrendMatrix value score: 7.1/10. Verdict: Hold.

What do analysts say about THC?

27 analysts cover THC with a consensus score of 4.1/5. Average price target: $243.

What does Tenet Healthcare Corporation do?Tenet Healthcare operates 50 acute care and specialty hospitals with 12,494 licensed beds across eight states alongside...

Tenet Healthcare operates 50 acute care and specialty hospitals with 12,494 licensed beds across eight states alongside 533 ambulatory surgery centers and 26 surgical hospitals in 37 states, employing nearly 100,000 people. Revenue flows through Hospital Operations (where managed care payers account for ~70% of segment net patient service revenues) and the Ambulatory Care segment via USPI's ASC and surgical hospital network.

Related stocks: UHS (Universal Health Services, Inc.) · AVAH (Aveanna Healthcare Holdings Inc) · ASTH (Astrana Health Inc.) · EHC (Encompass Health Corporation) · MD (Pediatrix Medical Group, Inc.)
Home Stocks THC

Latest news

Latest News

MSN68d ago
StockStory68d agoEarnings
MSN68d agoEarnings
GuruFocus68d ago
MSN75d ago
GuruFocus75d ago
Qz.com46d ago
Yahoo Finance47d ago
Seeking Alpha40d agoLegal
Yahoo Finance41d ago
Yahoo Finance41d ago
Insider Monkey41d ago
Marketscreener.com67d agoEarnings
Marketscreener.com67d agoEarnings
TradingView67d agoEarnings
Quiver Quantitative67d agoEarnings
Yahoo Finance74d ago
MarketBeat74d agoEarnings
Yahoo Finance46d ago
DirectorsTalk Interviews42d ago
Loading more...